Warsaw Orthopedic Company Expands Portfolio

OrthoPediatrics went public in October 2017. (photo courtesy Nasdaq)

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

Warsaw-based OrthoPediatrics Corp. (NASDAQ:KIDS) has acquired Vilex in Tennessee Inc. The company sold for a total of $60 million, consisting of $50 million in cash and $10 million in stock. 

Vilex is primarily a foot and ankle surgery company with a product portfolio targeting pediatric patients and adults.The transaction includes its Orthex Hexapod circular fixation technology and proprietary CORA-based x-ray planning software as well as its subsidiary Orthex LLC.

“This transaction closes the biggest gap in our Trauma & Deformity product offering.  It increases our coverage of the Trauma & Deformity market from 60% to 80%, while also adding a number of foundational products in pediatric foot and ankle surgery in anticipation of the imminent launch of our PediFoot system.  It also expands OP’s surgeon base to those deformity correction surgeons who treat children but may not practice in pediatric hospitals,” said Mark Throdahl, president and chief executive officer of OrthoPediatrics, in a news release.”